Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cube Labs SpAMIL:CUBE 67 3-Year EBITDA Growth Rate is 113.00% as of Dec. 2025, which is 210% above its 10-year median of 36.40. GuruFocus rates MIL:CUBE with a GF Score™ of 67/100 and a GF Value™ of €3.37 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 510 Asset Management companies, Cube Labs SpA ranks better than 96.67% on this metric.
During the past 3 years, the average EBITDA Per Share Growth Rate was 113.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 8 years, the highest 3-Year average EBITDA Per Share Growth Rate of Cube Labs SpA was 113.00% per year. The lowest was -40.20% per year. And the median was 36.40% per year.
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Cube Labs SpA 3-Year EBITDA Growth Rate Related Terms
MIL:CUBE vs BLK, BX, KKR: 3-Year EBITDA Growth Rate Comparison
For the Asset Management subindustry, Cube Labs SpA's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cube Labs SpA 3-Year EBITDA Growth Rate vs Asset Management Industry
For the Asset Management industry and Financial Services sector, Cube Labs SpA's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Cube Labs SpA's 3-Year EBITDA Growth Rate falls into.
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 113.00% mean?
Cube Labs SpA (MIL:CUBE) has a 3-Year EBITDA Growth Rate of 113.00% as of Dec. 2025. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Cube Labs SpA and its competitors. This is 210% above median its historical median of 36.40. According to the industry distribution chart, Cube Labs SpA ranks #17 out of 510 companies in the Asset Management industry, placing it in the top 3.3%.
Is Cube Labs SpA's 3-Year EBITDA Growth Rate too high?
Cube Labs SpA's current 3-Year EBITDA Growth Rate of 113.00% is 210% above median its 10-year median of 36.40. The Asset Management industry median 3-Year EBITDA Growth Rate is 10.90. Cube Labs SpA's value of 113.00% is 936.7% above this industry median. Based on the distribution chart, Cube Labs SpA ranks #17 out of 510 companies in the Asset Management industry, which is in the top quartile — a strong position relative to peers. Overall, Cube Labs SpA has a GF Score™ of 67/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Cube Labs SpA's 3-Year EBITDA Growth Rate compare to BLK and BX?
According to the Asset Management industry distribution chart, Cube Labs SpA ranks #17 out of 510 companies for 3-Year EBITDA Growth Rate. This places Cube Labs SpA in the top 3% of its industry — outperforming the majority of peers. The industry median 3-Year EBITDA Growth Rate is 10.90. Cube Labs SpA's value of 113.00% is 936.7% above this benchmark. While the company's 10-year median is 36.40 vs. the industry median of 10.90, Cube Labs SpA has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for an Asset Management company?
The median 3-Year EBITDA Growth Rate among Asset Management companies is 10.90, based on 510 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cube Labs SpA's current 3-Year EBITDA Growth Rate of 113.00% is 936.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Cube Labs SpA and its competitors. For the Asset Management industry, the median 3-Year EBITDA Growth Rate is 10.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cube Labs SpA's current 3-Year EBITDA Growth Rate is 113.00%, which is 210% above median its own 10-year median of 36.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cube Labs SpA stock overvalued right now?
Based on GuruFocus' analysis, Cube Labs SpA (MIL:CUBE) is currently considered Significantly Undervalued. The stock's GF Value™ is €3.37, compared to a current price of €2.34 — trading 30.6% below its estimated fair value. The current 3-Year EBITDA Growth Rate is 113.00%, which is 210% above median its 10-year median of 36.40 and 936.7% above the Asset Management industry median of 10.90. Cube Labs SpA's overall GF Score™ is 67/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Cube Labs SpA (MIL:CUBE), the current 3-Year EBITDA Growth Rate is 113.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cube Labs SpA (MIL:CUBE) Overvalued in 2026?
Based on GuruFocus' analysis, Cube Labs SpA stock appears to be undervalued.
The current stock price of €2.34 is trading 30.6% below its estimated GF Value™ of €3.37.
GuruFocus considers Cube Labs SpA to be Significantly Undervalued.
Key valuation signals for MIL:CUBE:
3-Year EBITDA Growth Rate: 113.00% (210% above median its 10-year median of 36.40)
GF Value™: €3.37 vs. price of €2.34 (30.6% below fair value)
Industry Position: 936.7% above the Asset Management median (#17 of 510)
No single metric tells the full story. See the MIL:CUBE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cube Labs SpA operates as a venture builder that enables innovation in the healthcare technology space. The company is engaged in attracting sources of financing and providing entrepreneurial and operational support to the companies to develop healthcare technologies for the market.
67GF Score
Get the complete analysis for MIL:CUBE
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIL:CUBE has been successfully added to your 
